Changes in the rates and characteristics of gamma hydroxybutyrate (GHB)‐related death in Australia, 2001–2023
GHB-related death rates increased from 2016, accompanied by changes in case characteristics. In recent years GHB use appears to have extended to a population more likely to have substance use problems and use other respiratory depressants.
Authors
- Johan A Duflou (ORCID: https://orcid.org/0000-0001-5863-635X)
- Amy Peacock (ORCID: https://orcid.org/0000-0002-5705-2026)
- Shane G Darke (ORCID: https://orcid.org/0000-0001-8718-7055)
- Julia Lappin (ORCID: https://orcid.org/0000-0001-5946-2144)
- Michael Farrell (ORCID: https://orcid.org/0000-0001-7008-8130)
- Agata Chrzanowska (ORCID: https://orcid.org/0000-0002-1811-7851)
Institutions
- The University of Sydney (AU)
- UNSW Sydney (AU)
Publication Details
- Journal
- Drug and Alcohol Review
- Published
- 2024-09-05
- DOI
- https://doi.org/10.1111/dar.13940
- Citations
- 4
- Primary Topic
- Forensic Toxicology and Drug Analysis
- Type
- article
- Field-Weighted Citation Impact
- 1.40
Funders
- U.S. Department of Justice
- Indivior
- Australian Government
- National Coronial Information System
- Seqirus
- National Health and Medical Research Council
- National Drug and Alcohol Research Centre